Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Related Citations for PubMed (Select 24879033)

1.

Three different histological subtypes of Epstein-Barr virus-negative post-transplant lymphoproliferative disorder in a patient with hepatitis C infection.

Kobayashi M, Asano N, Fukushima M, Honda T.

Int J Hematol. 2014 Sep;100(3):307-11. doi: 10.1007/s12185-014-1599-6. Epub 2014 May 31.

PMID:
24879033
2.

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

Kinch A, Baecklund E, Backlin C, Ekman T, Molin D, Tufveson G, Fernberg P, Sundström C, Pauksens K, Enblad G.

Acta Oncol. 2014 May;53(5):669-79. doi: 10.3109/0284186X.2013.844853. Epub 2013 Oct 28.

PMID:
24164103
3.

[Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].

Chen DB, Wang Y, Song QJ, Shen DH.

Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):607-12. doi: 10.3760/cma.j.issn.0529-5807.2012.09.008. Chinese.

PMID:
23157829
5.

Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.

Miyagi S, Sekiguchi S, Kawagishi N, Akamatsu Y, Satoh K, Takeda I, Fukushima D, Kobayashi Y, Tokodai K, Fujimori K, Satomi S.

Transplant Proc. 2011 Nov;43(9):3299-301. doi: 10.1016/j.transproceed.2011.10.002.

PMID:
22099782
6.

Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation.

Chen DB, Song QJ, Chen YX, Chen YH, Shen DH.

Int J Hematol. 2013 Jan;97(1):117-24. doi: 10.1007/s12185-012-1244-1. Epub 2012 Dec 20.

PMID:
23255160
7.

[Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].

Filipec-Kanizaj T, Budimir J, Colić-Cvrlje V, Kardum-Skelin I, Sustercić D, Naumovski-Mihalić S, Mrzljak A, Kolonić SO, Sobocan N, Bradić T, Dolić ZM, Kocman B, Katicić M, Zidovec-Lepej S, Vince A.

Acta Med Croatica. 2011 Sep;65 Suppl 1:37-43. Croatian.

PMID:
23126028
8.

Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.

Wasson S, Zafar MN, Best J, Reddy HK.

J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):77-83.

PMID:
16703222
9.

Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.

Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ.

Am J Surg Pathol. 2006 Mar;30(3):328-36.

PMID:
16538052
10.

Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.

Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.

Pediatr Transplant. 2009 Feb;13(1):54-62. doi: 10.1111/j.1399-3046.2008.00969.x. Epub 2008 Jun 1.

PMID:
18518912
11.

Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.

Ganne V, Siddiqi N, Kamaplath B, Chang CC, Cohen EP, Bresnahan BA, Hariharan S.

Clin Transplant. 2003 Oct;17(5):417-22.

PMID:
14703923
12.

Autopsy pathology of pediatric posttransplant lymphoproliferative disorder.

Collins MH, Montone KT, Leahey AM, Hodinka RL, Salhany KE, Belchis DA, Tomaszewski JE.

Pediatrics. 2001 Jun;107(6):E89.

PMID:
11389287
13.

Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.

Zimmermann H, Reinke P, Neuhaus R, Lehmkuhl H, Oertel S, Atta J, Planker M, Gärtner B, Lenze D, Anagnostopoulos I, Riess H, Trappe RU.

Cancer. 2012 Oct 1;118(19):4715-24. doi: 10.1002/cncr.27482. Epub 2012 Mar 5.

14.

Rational management of posttransplant lymphoproliferative disorder in pediatric recipients.

Praghakaran K, Wise B, Chen A, Schwarz K, Colombani P.

J Pediatr Surg. 1999 Jan;34(1):112-5; discussion 115-6.

PMID:
10022154
15.

Hashimoto's encephalopathy after interferon therapy for hepatitis C virus in adult liver transplant recipient accompanied by post-transplant lymphoproliferative disorder related to Epstein-Barr virus infection.

Hori T, Oike F, Hata K, Nishikiori M, Ogura Y, Ogawa K, Takada Y, Egawa H, Nguyen JH, Uemoto S.

Transpl Infect Dis. 2010 Aug 1;12(4):347-52. doi: 10.1111/j.1399-3062.2010.00508.x. Epub 2010 Apr 26.

PMID:
20456713
16.

Thoracic presentations of posttransplant lymphoproliferative disorders.

Halkos ME, Miller JI, Mann KP, Miller DL, Gal AA.

Chest. 2004 Dec;126(6):2013-20.

PMID:
15596707
17.

Posttransplant lymphoproliferative disorder in pediatric renal transplantation.

Srivastava T, Zwick DL, Rothberg PG, Warady BA.

Pediatr Nephrol. 1999 Nov;13(9):748-54.

PMID:
10603113
18.

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

Trappe R, Oertel S, Leblond V, Mollee P, Sender M, Reinke P, Neuhaus R, Lehmkuhl H, Horst HA, Salles G, Morschhauser F, Jaccard A, Lamy T, Leithäuser M, Zimmermann H, Anagnostopoulos I, Raphael M, Riess H, Choquet S; German PTLD Study Group; European PTLD Network.

Lancet Oncol. 2012 Feb;13(2):196-206. doi: 10.1016/S1470-2045(11)70300-X. Epub 2011 Dec 13.

PMID:
22173060
19.

Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.

Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.

J Clin Oncol. 2009 Jul 10;27(20):3354-62. doi: 10.1200/JCO.2008.20.0857. Epub 2009 May 18.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk